3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
8
Skin Neoplasms
6
Neoplasms
6
Melanoma
5
Squamous Cell Carcinoma of Head and Neck
4
Carcinoma, Squamous Cell
4
Neoplasm Metastasis
3
Prostatic Neoplasms
2
Lung Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Merkel Cell
2
Advanced Non-Small Cell Lung Cancer
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Resectable Non-small Cell Lung Cancer
1
Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
1
Recurrence
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Multiple Myeloma
1
Mouth Neoplasms
1
Motor Activity
1
Liposarcoma
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Interventions
Surgical Procedures, Operative
2
Paclitaxel
2
Doxorubicin
2
Cyclophosphamide
2
Carboplatin
2
pertuzumab
1
liposomal doxorubicin
1
cemiplimab
1
atezolizumab
1
Trastuzumab
1
Radiotherapy
1
Indocyanine Green
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Invasive Breast Cancer
×
cemiplimab
×
Clear all
NCT04243616
2025-09-05
CemiHALT
Medical College of Wisconsin
Phase 2
Active not recruiting
36 enrolled